(Q40289681)

19 September 2017

1 reference

title

DDMP (2,4-diamino-5-(3',4'-dichlorophenyl)-methylpyrimidine). (English)

1 reference

19 September 2017

Hill BT

1

1 reference

19 September 2017

Price LA

series ordinal

2

1 reference

19 September 2017

publication date

1 June 1980

1 reference

19 September 2017

published in

Cancer Treatment Reviews

1 reference

19 September 2017

volume

7

1 reference

19 September 2017

issue

2

1 reference

19 September 2017

page(s)

95-112

1 reference

Initial clinical experience with a simultaneous combination of 2,4-diamino-5(3?,4?-dichlorophenyl)-6-methylpyrimidine (DDMP) with folinic acid

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2880%2980019-3

7 January 2021

Letter: Pyrimethamine in central-nervous-system leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2880%2980019-3

7 January 2021

Protection with single-dose folinic acid against bone-marrow depression by long-acting diaminopyrimidines

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2880%2980019-3

7 January 2021

Elevation of brain histamine levels by diaminopyrimidine inhibitors of histamine N-methyl transferase

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2880%2980019-3

7 January 2021

Antimalarials as Antagonists of Purines and Pteroylglutamic Acid

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2880%2980019-3

7 January 2021

Effects of DDMP and DDEP on the deoxyribonucleoside triphosphate concentrations in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2880%2980019-3

7 January 2021

Letter: Pyrimethamine in prophylaxis of meningeal leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2880%2980019-3

7 January 2021

Lethal and kinetic effects of DDMP (2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine)

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2880%2980019-3

7 January 2021

Studies concerned with overcoming resistance to methotrexate: a comparison of the effects of methotrexate and 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (BW50197) on the colony forming ability of L5178Y cells

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2880%2980019-3

7 January 2021

Methotrexate resistance and uptake of DDMP by L5178Y cells. Selective protection with folinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2880%2980019-3

7 January 2021

The difference between “selective folinic acid protection” and “folinic acid rescue” in L5178Y cells culture

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2880%2980019-3

7 January 2021

Dihydrofolate reductase from Trypanosoma equiperdum. II. Inhibition by 2,4-diaminopyrimidines and related heterocycles

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2880%2980019-3

7 January 2021

Daraprim in treatment of malaria; a study of its effects in falciparum and quartan infections in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2880%2980019-3

7 January 2021

Clinical effects of the dichloro and monochlorophenyl analogues of diamino pyrimidine: antagonists of folic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2880%2980019-3

7 January 2021

Studies on dihydrofolate reductase related to the drug sensitivity of microbial and neoplastic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2880%2980019-3

7 January 2021

Long plasma half-life of pyrimethamine

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2880%2980019-3

7 January 2021

Methodichlorophen as anti-tumor drug

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2880%2980019-3

7 January 2021

Pyrimethamine in central-nervous-system leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2880%2980019-3

7 January 2021

Comparison of the Antitumor Activity and Toxicity of 2,4-Diamino-5-(1-adamantyl)-6- methylpyrimidine and 2,4-Diamino-5-(1-adamantyl)-6-ethylpyrimidine 2

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2880%2980019-3

7 January 2021

10.1016/S0305-7372(80)80019-3

Identifiers

DOI

1 reference

19 September 2017

1 reference